Clinical Implication of Serosal Change in Pathologic Subserosa‐Limited Gastric Cancer
- 7 December 2011
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 36 (2) , 355-361
Abstract
Background The aim of this study was to evaluate the clinical implication of serosal change in pathologic subserosa-limited gastric cancer based on a retrospective analysis. Methods A total of 285 patients who were diagnosed with pathologically subserosa-limited gastric cancer were included. The patients were divided into two groups: the accordance group, with subserosa-limited cancer without macroscopic serosa change (n = 124); the discordance group, with subserosa-limited cancer showing macroscopic serosal change (n = 161). Results Tumor size, number of metastatic lymph nodes, and pathologic N stage were significantly associated with macroscopic serosal change. Serosal change patients presented a higher recurrence rate compared with patients without serosal change (38.0 vs. 20.2% for the 5-year recurrence rate, P = 0.002), and peritoneal seeding presented frequently in serosal-change patients with significance (41.1%). Likewise, the overall survival of serosal-change patients was significantly worse than that for those without serosal change (66.9 vs. 81.4% for the 5-year survival rate, P = 0.002). Serosal change was an independent prognostic factor for overall survival (relative risk 1.784, P = 0.039). Conclusions Serosal change in pathologic subserosa-limited gastric cancer is related to poor survival. Therefore, adjuvant chemotherapy should be considered for these patients, and adequate follow-up programs instituted for early detection of peritoneal seeding.Keywords
This publication has 26 references indexed in Scilit:
- Gastrointestinal cancer metastasis and lymphatic advancementSurgery Today, 2010
- Evaluation of Venous Invasion by Elastica van Gieson Stain and Tumor Budding Predicts Local and Distant Metastases in Patients With T1 Stage Colorectal CancerAmerican Journal of Surgical Pathology, 2009
- Prognostic value of subclassification of T2 tumours in patients with gastric cancerBritish Journal of Surgery, 2009
- Role of staging laparoscopy with peritoneal lavage cytology in the treatment of locally advanced gastric cancerGastric Cancer, 2007
- Serosal involvement in gastrointestinal cancer: its assessment and significanceHistopathology, 2005
- Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermiaThe Lancet Oncology, 2004
- Magnitude of Serosal Changes Predicts Peritoneal Recurrence of Gastric CancerJournal of the American College of Surgeons, 2003
- Prospective study of peritoneal recurrence after curative surgery for gastric cancerBritish Journal of Surgery, 2003
- Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancerSurgical Oncology, 1992
- Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancerBritish Journal of Surgery, 1990